151 related articles for article (PubMed ID: 16023013)
1. Gemcitabine inhibits viability, growth, and metastasis of osteosarcoma cell lines.
Ando T; Ichikawa J; Okamoto A; Tasaka K; Nakao A; Hamada Y
J Orthop Res; 2005 Jul; 23(4):964-9. PubMed ID: 16023013
[TBL] [Abstract][Full Text] [Related]
2. Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases.
Koshkina NV; Kleinerman ES
Int J Cancer; 2005 Sep; 116(3):458-63. PubMed ID: 15800950
[TBL] [Abstract][Full Text] [Related]
3. Eradication of osteosarcoma lung metastasis using intranasal gemcitabine.
Jia SF; Worth LL; Turan M; Duan Xp XP; Kleinerman ES
Anticancer Drugs; 2002 Feb; 13(2):155-61. PubMed ID: 11901308
[TBL] [Abstract][Full Text] [Related]
4. Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
McMahon MB; Bear MD; Kulp SK; Pennell ML; London CA
Am J Vet Res; 2010 Jul; 71(7):799-808. PubMed ID: 20594083
[TBL] [Abstract][Full Text] [Related]
5. Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.
Gordon N; Kleinerman ES
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):189-96. PubMed ID: 20528149
[TBL] [Abstract][Full Text] [Related]
6. Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs.
Rodriguez CO; Crabbs TA; Wilson DW; Cannan VA; Skorupski KA; Gordon N; Koshkina N; Kleinerman E; Anderson PM
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):197-206. PubMed ID: 19803732
[TBL] [Abstract][Full Text] [Related]
7. Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine.
Gordon N; Koshkina NV; Jia SF; Khanna C; Mendoza A; Worth LL; Kleinerman ES
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4503-10. PubMed ID: 17671136
[TBL] [Abstract][Full Text] [Related]
8. Licoricidin enhances gemcitabine-induced cytotoxicity in osteosarcoma cells by suppressing the Akt and NF-κB signal pathways.
Wang Y; Wang S; Liu J; Lu Y; Li D
Chem Biol Interact; 2018 Jun; 290():44-51. PubMed ID: 29782821
[TBL] [Abstract][Full Text] [Related]
9. lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway.
Sun ZY; Jian YK; Zhu HY; Li B
Pathol Res Pract; 2019 Mar; 215(3):555-563. PubMed ID: 30661902
[TBL] [Abstract][Full Text] [Related]
10. Enhanced anticancer effect of gemcitabine by genistein in osteosarcoma: the role of Akt and nuclear factor-kappaB.
Zhang B; Shi ZL; Liu B; Yan XB; Feng J; Tao HM
Anticancer Drugs; 2010 Mar; 21(3):288-96. PubMed ID: 20038829
[TBL] [Abstract][Full Text] [Related]
11. Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma.
Wu W; Dai Y; Liu H; Cheng R; Ni Q; Ye T; Cui W
Drug Deliv; 2018 Nov; 25(1):1642-1651. PubMed ID: 30799654
[TBL] [Abstract][Full Text] [Related]
12. Genistein potentiates the anti-cancer effects of gemcitabine in human osteosarcoma via the downregulation of Akt and nuclear factor-κB pathway.
Liang C; Li H; Shen C; Lai J; Shi Z; Liu B; Tao HM
Anticancer Agents Med Chem; 2012 Jun; 12(5):554-63. PubMed ID: 22263786
[TBL] [Abstract][Full Text] [Related]
13. Antimetastatic activity of honokiol in osteosarcoma.
Steinmann P; Walters DK; Arlt MJ; Banke IJ; Ziegler U; Langsam B; Arbiser J; Muff R; Born W; Fuchs B
Cancer; 2012 Apr; 118(8):2117-27. PubMed ID: 21935912
[TBL] [Abstract][Full Text] [Related]
14. Autophagy in osteosarcoma.
O'Farrill JS; Gordon N
Adv Exp Med Biol; 2014; 804():147-60. PubMed ID: 24924173
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
[TBL] [Abstract][Full Text] [Related]
16. Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma.
Mori S; Ueda T; Kuratsu S; Hosono N; Izawa K; Uchida A
Int J Cancer; 1995 Mar; 61(1):148-52. PubMed ID: 7535752
[TBL] [Abstract][Full Text] [Related]
17. Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas.
Kreahling JM; Foroutan P; Reed D; Martinez G; Razabdouski T; Bui MM; Raghavan M; Letson D; Gillies RJ; Altiok S
PLoS One; 2013; 8(3):e57523. PubMed ID: 23520471
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis by gemcitabine in non-small cell lung cancer cell line KNS62 is induced downstream of caspase 8 and is profoundly blocked by Bcl-xL over-expression.
Kurdow R; Schniewind B; Zoefelt S; Boenicke L; Boehle AS; Dohrmann P; Kalthoff H
Langenbecks Arch Surg; 2005 Jun; 390(3):243-8. PubMed ID: 15726400
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of human osteosarcoma HuO9 cells by methylglyoxal bis(cyclopentylamidinohydrazone) in vitro and in vivo.
Satoh N; Hibasami H; Mori K; Kaneko H; Wakabayashi H; Hirata K; Sonoda J; Nakashima K; Uchida A
Oncol Rep; 1999; 6(3):627-30. PubMed ID: 10203604
[TBL] [Abstract][Full Text] [Related]
20. Involvement of p53 in gemcitabine mediated cytotoxicity and radiosensitivity in breast cancer cell lines.
Salem SD; Abou-Tarboush FM; Saeed NM; Al-Qadasi WD; Farah MA; Al-Buhairi M; Al-Harbi N; Alhazza I; Alsbeih G
Gene; 2012 May; 498(2):300-7. PubMed ID: 22353361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
